Evidence map›Paper›PMID 31483847›Full record

ArticlePloS one2019

Increased functional connectivity of thalamic subdivisions in patients with Parkinson's disease.

Conor Owens-Walton, David Jakabek, Brian D Power, Mark Walterfang, Dennis Velakoulis, Danielle van Westen, Jeffrey C L Looi, Marnie Shaw, Oskar Hansson

Registry-linked trialAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07599592 (Open Label Study for the Use of Low Intensity Focused Ultrasound for Essential Tremor), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07599592 early_phase1recruitingnot on this mapstarted 2026, after this paper: background citation

Open Label Study for the Use of Low Intensity Focused Ultrasound for Essential Tremor

TypeinterventionalSponsorUniversity of California, Los AngelesRan2026 to 2027Enrolled20ConditionsEssential TremorArmsLow Intensity Focused Ultrasound (LIFU)
3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Article
  3. Temporal Dynamics of Parkinson's Disease Tremor: Clinical and Neuroimaging Insights.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Disuse-driven plasticity in the human thalamus and putamen.bioRxiv : the preprint server for biology · 2024
    Article
  12. Article
  13. Combining CRISPR-Cas9 and brain imaging to study the link from genes to molecules to networks.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Conor Owens-WaltonResearch Centre for the Neurosciences of Ageing, Academic Unit of Psychiatry and Addiction Medicine, School of Clinical Medicine, Medical School, Australian National University, Canberra, Australia.ORCID 0000-0003-0589-638X
David JakabekGraduate School of Medicine, University of Wollongong, Wollongong, Australia.
Brian D PowerSchool of Medicine, The University of Notre Dame, Fremantle, Australia.
Mark WalterfangNeuropsychiatry Unit, Royal Melbourne Hospital, Melbourne Neuropsychiatry Centre, University of Melbourne & Northwestern Mental Health, Melbourne, Australia.ORCID 0000-0002-1389-3691
Dennis VelakoulisNeuropsychiatry Unit, Royal Melbourne Hospital, Melbourne Neuropsychiatry Centre, University of Melbourne & Northwestern Mental Health, Melbourne, Australia.
Danielle van WestenCenter for Medical Imaging and Physiology, Skåne University Hospital, Lund, Sweden.
Jeffrey C L LooiResearch Centre for the Neurosciences of Ageing, Academic Unit of Psychiatry and Addiction Medicine, School of Clinical Medicine, Medical School, Australian National University, Canberra, Australia.
Marnie ShawCollege of Engineering and Computer Science, The Australian National University, Canberra, Australia.
Oskar HanssonMemory Clinic, Skåne University Hospital, Malmö, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) affects 2-3% of the population over the age of 65 with loss of dopaminergic neurons in the substantia nigra impacting the functioning of basal ganglia-thalamocortical circuits. The precise role played by the thalamus is unknown, despite its critical role in the functioning of the cerebral cortex, and the abnormal neuronal activity of the structure in PD. Our objective was to more clearly elucidate how functional connectivity and morphology of the thalamus are impacted in PD (n = 32) compared to Controls (n = 20). To investigate functional connectivity of the thalamus we subdivided the structure into two important regions-of-interest, the first with putative connections to the motor cortices and the second with putative connections to prefrontal cortices. We then investigated potential differences in the size and shape of the thalamus in PD, and how morphology and functional connectivity relate to clinical variables. Our data demonstrate that PD is associated with increases in functional connectivity between motor subdivisions of the thalamus and the supplementary motor area, and between prefrontal thalamic subdivisions and nuclei of the basal ganglia, anterior and dorsolateral prefrontal cortices, as well as the anterior and paracingulate gyri. These results suggest that PD is associated with increased functional connectivity of subdivisions of the thalamus which may be indicative alterations to basal ganglia-thalamocortical circuitry.

Indexed as

AgedFemaleHumansMagnetic Resonance ImagingMaleMotor CortexNeural PathwaysParkinson DiseasePrefrontal CortexThalamus

Identifiers

PMID31483847
PMCPMC6726201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.